Protein Sciences Corp Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Meriden CT United States (1983)
Status: Acquired by Sanofi-Aventis (2017)

Organization Overview

First Clinical Trial
1999
NCT00000762
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

MicroGeneSys Inc | MicroGeneSys Inc (nka Protein Sciences Corporation) | Protein Sciences Corporation